Inclusion Body Myositis
- 1 December 2016
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in CONTINUUM: Lifelong Learning in Neurology
- Vol. 22 (6), 1871-1888
- https://doi.org/10.1212/01.con.0000511071.58338.1e
Abstract
Inclusion body myositis (IBM) is an enigmatic progressive disease of skeletal muscle. This review provides a summary of the clinical and pathophysiologic aspects of IBM. The development of diagnostic blood testing for IBM followed from the discovery of a B-cell pathway in IBM muscle and circulating autoantibodies against NT5C1A, further establishing IBM's status as an autoimmune disease. The key role of cytotoxic T cells in IBM is further supported by the identification of a link between IBM and T-cell large granular lymphocytic leukemia. The testing of research diagnostic criteria in patients is improving its accuracy. Increases in estimated prevalences may be due to a combination of true increases and improved recognition of disease. IBM has high unmet medical need. Advances in the mechanistic understanding of IBM as an autoimmune disease will drive effective therapeutic approaches. The identification of a B-cell pathway has resulted in the first identification of an IBM autoantigen and emphasized its status as an autoimmune disease. The recognition that large granular lymphocyte CD8+ T-cell expansions are present in both blood and muscle provides additional biomarkers for IBM and suggests a mechanistic relationship to the neoplastic disease T-cell large granular lymphocytic leukemia.Keywords
This publication has 56 references indexed in Scilit:
- High prevalence of inclusion body myositis in Norway; a population‐based clinical epidemiology studyEuropean Journal of Neurology, 2014
- Cytoplasmic 5′‐nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utilityMuscle & Nerve, 2014
- Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositisAnnals of Neurology, 2012
- Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositisAnnals of Neurology, 2012
- Long-term observational study of sporadic inclusion body myositisBrain, 2011
- Increase in number of sporadic inclusion body myositis (sIBM) in JapanZeitschrift für Neurologie, 2011
- Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body MyositisPLOS ONE, 2011
- Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian casesJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Inclusion body myositisZeitschrift für Neurologie, 2005
- Patterns of muscle involvement in inclusion body myositis: Clinical and magnetic resonance imaging studyMuscle & Nerve, 2001